K030477 is an FDA 510(k) clearance for the DIADEXUS PLAC TEST. This device is classified as a Test, System, Immunoassay, Lipoprotein-associated Phospholipase A2 (Class II - Special Controls, product code NOE).
Submitted by Diadexus, Inc. (South San Francisco, US). The FDA issued a Cleared decision on July 18, 2003, 155 days after receiving the submission on February 13, 2003.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5600. The Lipoprotein-associated Phospholipase A2, Immunoassay, System, Test, Is Intended To Measure Lipoprotein-associated Phospholipase A2 In Human Plasma In Conjunction With Clinical Evaluation And Other Patient Risk Factors Including Biochemical Analyses As An Aid In Predicting Risk For Coronary Heat Disease. This Device Differs From The Classification Regulation In That It Is A Different Analyte, Thus A New Marker For Predicting Risk Of Coronary Heart Disease. This Device Is Measuring An Enzyme That Is Produced By Macrophages Where As The Regulation Is For The Measurement Of A Lipoprotein..